Evoke Pharma Inc.

NASDAQ: EVOK · Real-Time Price · USD
5.08
-0.06 (-1.17%)
At close: Aug 15, 2025, 3:01 PM

Evoke Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-5.35M -7.79M -8.22M -8.54M
Depreciation & Amortization
n/a n/a n/a n/a
Stock-Based Compensation
773.12K 1.13M 1.46M 1.88M
Other Working Capital
n/a 1.14M 505.61K -4.84M
Other Non-Cash Items
518.05K 129.07K 37.02K -75.13K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-1.4M 1.55M 132.41K -5.62M
Operating Cash Flow
-5.46M -4.98M -6.6M -12.35M
Capital Expenditures
n/a -3 n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
-191 n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-191 -119.3K -148.99K -1.27M
Financial Cash Flow
14.32M -119.3K 7.29M 13.43M
Net Cash Flow
8.86M -5.1M 698.99K 1.08M
Free Cash Flow
-5.46M -4.98M -6.6M -12.35M